ATE280778T1 - Verfahren zur behandlung von mikrobiellen infektionen mittles entkupplung des phosphotransferase-systems und dazu geeingnete wirkstoffe - Google Patents

Verfahren zur behandlung von mikrobiellen infektionen mittles entkupplung des phosphotransferase-systems und dazu geeingnete wirkstoffe

Info

Publication number
ATE280778T1
ATE280778T1 AT98101704T AT98101704T ATE280778T1 AT E280778 T1 ATE280778 T1 AT E280778T1 AT 98101704 T AT98101704 T AT 98101704T AT 98101704 T AT98101704 T AT 98101704T AT E280778 T1 ATE280778 T1 AT E280778T1
Authority
AT
Austria
Prior art keywords
pts
uncoupling
phosphoenolpyruvate
phosphotransferase system
compounds
Prior art date
Application number
AT98101704T
Other languages
English (en)
Inventor
Bernhard Erni
Original Assignee
Arpida Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arpida Ag filed Critical Arpida Ag
Application granted granted Critical
Publication of ATE280778T1 publication Critical patent/ATE280778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
AT98101704T 1997-02-19 1998-02-02 Verfahren zur behandlung von mikrobiellen infektionen mittles entkupplung des phosphotransferase-systems und dazu geeingnete wirkstoffe ATE280778T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97102616 1997-02-19

Publications (1)

Publication Number Publication Date
ATE280778T1 true ATE280778T1 (de) 2004-11-15

Family

ID=8226491

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98101704T ATE280778T1 (de) 1997-02-19 1998-02-02 Verfahren zur behandlung von mikrobiellen infektionen mittles entkupplung des phosphotransferase-systems und dazu geeingnete wirkstoffe

Country Status (4)

Country Link
US (1) US6245502B1 (de)
JP (1) JPH10327894A (de)
AT (1) ATE280778T1 (de)
DE (1) DE69827179T2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518911A (en) * 1995-01-06 1996-05-21 Onyx Pharmaceuticals, Inc. Human PAK65
US5700675A (en) * 1995-12-13 1997-12-23 Regents Of The University Of California Protein kinase required for Ras signal transduction

Also Published As

Publication number Publication date
JPH10327894A (ja) 1998-12-15
DE69827179D1 (de) 2004-12-02
DE69827179T2 (de) 2005-03-10
US6245502B1 (en) 2001-06-12

Similar Documents

Publication Publication Date Title
Ronneau et al. Make and break the alarmone: regulation of (p) ppGpp synthetase/hydrolase enzymes in bacteria
Francis et al. Multikinase networks: two-component signaling networks integrating multiple stimuli
Izaki et al. Glycopeptide transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reactions.
Silver Novel inhibitors of bacterial cell wall synthesis
Wyke et al. A role in vivo for penicillin‐binding protein‐4 of Staphylococcus aureus
Cozzone et al. Protein phosphorylation on tyrosine in bacteria
Siewert et al. Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls
Work The mucopeptides of bacterial cell walls. A review
Berlicki Inhibitors of glutamine synthetase and their potential application in medicine
Chambers et al. Bacterial virulence mediated by orthogonal post-translational modification
Kinoshita et al. Association of fusidic acid sensitivity with G factor in a protein-synthesizing system
Kushwaha et al. Stringent response protein as a potential target to intervene persistent bacterial infection
Stinson et al. Secretion of phospholipase C by Pseudomonas aeruginosa
Müller et al. Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors
Michaud et al. Partial purification and specificity studies of the d‐glutamate‐adding and d‐alanyl‐d‐alanine‐adding enzymes from Escherichia coli K12
Eisenbach A hitchhiker's guide through advances and conceptual changes in chemotaxis
Mesters et al. Synergism between the GTPase activities of EF-Tu· GTP and EF-G· GTP on empty ribosomes: Elongation factors as stimulators of the ribosomal oscillation between two conformations
Strominger et al. How penicillin kills bacteria: progress and problems
Komiyama et al. Inhibitory effects of phosphoramidon on neutral metalloendopeptidases and its application on affinity chromatography
Zawadzke et al. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention
Muñoz et al. Monitoring host–pathogen interactions using chemical proteomics
Ball 11 2′, 5′-Oligoadenylate synthetase
Lorian The mode of action of antibiotics on gram-negative bacilli
DE69827179D1 (de) Verfahren zur Behandlung von mikrobiellen Infektionen mittles Entkupplung des Phosphotransferase-Systems und dazu geeingnete Wirkstoffe
EP0866075A3 (de) Verfahren zur Behandlung von mikrobiellen Infektionen mittles Entkupplung des Phosphotransferase-Systems und dazu geeingnete Wirkstoffe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties